Product Name | Anlotinib Dihydrochloride (AL3818 Dihydrochloride); Anlotinib 2HCl |
---|---|
CAS | 1360460-82-7 |
Formula | C23H24Cl2FN3O3 |
MW | 480.36 |
Appearance | Light yellow to yellow powder |
Anlotinib, also known as AL3818 and Catequentinib, is a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets multiple RTKs, including vascular endothelial growth factor receptor type 2 (VEGFR2) and type 3 (VEGFR3). This agent may both inhibit angiogenesis and halt tumor cell growth.
© Copyright 2015-2021 Chemleader Biomedical Co., Ltd. All Rights Reserved.
沪ICP备15046197号-4
沪公网安备31011502007856号
Designed by Kuanersoft